You can buy or sell Zosano Pharma and other stocks, options, ETFs, and crypto commission-free!
Zosano Pharma Corp. operates as a clinical stage pharmaceutical company that develops proprietary intracutaneous delivery system. It offers rapid absorption of drug, consistent drug delivery, improved ease of use and room-temperature stability, benefits that differentiate its delivery platform from other non-oral formulations or injections. Read More The company was founded in January 2012 and is headquartered in Fremont, CA.
52 Week High
52 Week Low
Seeking AlphaMar 14
Zosano Pharma Corporation (ZSAN) CEO John Walker on Q4 2018 Results - Earnings Call Transcript
Zosano Pharma Corporation (NASDAQ:ZSAN) Q4 2018 Earnings Conference Call March 14, 2019 4:30 PM ET Company Participants Greg Kitchener - Chief Financial Officer John Walker - Chairman & Chief Executive Officer Don Kellerman - Vice President, Clinical Development & Medical Affairs Conference Call Participants Bert Hazlett - BTIG Operator Good day, ladies and gentlemen, and welcome to the Zosano Pharma Inc. Fourth Quarter 2018 Earnings Conference Call. At this time, all participants are in a listen-on...
Markets InsiderMar 11
Zosano Pharma Announces Presentation and Participation at the 31st Annual Roth Conference
FREMONT, Calif., March 11, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its chairman, president and chief executive officer, John Walker, will participate in a panel titled “Drug Delivery” to be held on Monday, March 18, 2019 at 10:30 am PT at the 31st Annual Roth Conference. A live webcast of the panel will be available within the company’s website at https://ir.zosanopharma.com/events-presentations . In addition, the ...
Stock Price, News, & Analysis for Zosano Pharma
Media stories about ZSAN stock have trended somewhat positive on Monday, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Zosano Pharma earned a coverage optimism score of 1.1 on InfoTrie's scale. They also gave news coverage about the biote...
-$0.69 per share
-$0.85 per share